AML Clinical Trials Database - Free Access to 63 Studies
Access comprehensive clinical trial information for AML through Pure Global AI's free database. This collection includes 63 clinical trials across multiple phases including N/A, Phase 1, Early Phase 1. Currently, 19 trials are actively recruiting participants.
Research for AML is being conducted in China, United States of America, Spain and 7+ other countries. Leading sponsors include Zhejiang University and Institute of Hematology & Blood Diseases Hospital, China. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers
A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure
Drug-screening in AML at Relapse for Targeted Treatment
NKG2D CAR-NK & r/rAML
Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AML
Evaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AML
Evaluate the Safety and Efficacy of ADGRE2 CAR-T in Patients With R/R AML
Evaluate the Safety and Efficacy of CLL1 CAR-T in Patients With R/R AML
Universal CAR-γδT Cell Injection in the AML Patients
The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission
CC-486 and Venetoclax for Acute Myeloid Leukemia
Registry of Patients Having Received oNKord®
NK Cell Therapy for AML
Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological Malignancies
Clinical Study of CLL1 CAR-T Cells in the Treatment of Hematological Malignancies
Untitled Trial
A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD Relapse/Refractory (R/R) AML
Study to Assess an Interphase Cycle With Flotetuzumab.
Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AML
Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML
Pure Global AI provides free access to 63 clinical trials studying AML, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Zhejiang University, Institute of Hematology & Blood Diseases Hospital, China, PETHEMA Foundation, among others.